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Balloon angioplasty and intra-arterial stenting
have been highly successful in treating short, focal
arterial stenoses but are of limited use for longer
stenoses and arterial occlusions.1-5 Endovascular
grafts were developed to treat a variety of arterial
lesions that were not amenable to balloon angioplas-
ty alone or angioplasty in combination with stenting.
Arterial lesions such as long-segment aortoiliac
stenoses and occlusions, aneurysms, and traumatic
lesions have been successfully treated with endovas-
cular grafts because of the combination of the utili-
ty of balloon angioplasty and stenting with that of
conventional bypass grafts.6-11
Despite early clinical success, endovascular grafts
are in a developmental stage, and the applicability
and efficacy of these devices must therefore be con-
sidered unproved. Common features of endovascu-
lar procedures are the insertion of a prosthetic graft
through a remote vascular access site, delivery of the
device inside the lumen of an artery, and deployment
of the graft so as to bridge or obliterate the arterial
defect. Typically, the graft is anchored to the artery
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Purpose: Techniques for managing the distal anastomoses of aortofemoral and
iliofemoral endovascular grafts are described.
Methods: Over a 21⁄2-year period 46 endovascular grafts were successfully placed to treat
severe iliac artery occlusive disease. Endovascular grafts were anchored proximally in the
distal aorta or iliac arteries with Palmaz balloon-expandable stents. The distal anasto-
moses were performed with the use of open, sutured anastomotic techniques. In contrast
to stented distal anastomoses, these techniques allowed us to (1) treat occlusive lesions
extending from the distal aorta to below the inguinal ligament, (2) terminate endovas-
cular grafts in the groin where stents are contraindicated, (3) vary the distal anastomot-
ic site depending on the local pattern of disease, and (4) standardize the preinsertion
length of the endovascular graft.
Results: Two distal perianastomotic stenoses and one graft occlusion were detected postop-
eratively in 11 bypass grafts that had distal anastomoses sewn endoluminally without an
overlying patch angioplasty. Only one perianastomotic stenosis was found among 35 anas-
tomoses performed with other techniques. There were no significant differences in primary
and secondary patency between grafts originating in the distal aorta or iliac arteries.
Conclusions: Hand-sewn distal anastomoses can simplify the insertion of endovascular
grafts used for the treatment of aortoiliac occlusive disease. These anastomoses permit
tailoring of the graft according to the patients’ pattern of disease and eliminate the need
to precisely measure the length of the graft preoperatively. In addition, because a distal
stent is not required, endovascular grafts can be safely terminated in the groin instead
of the external iliac artery where disease progression can lead to graft failure. Finally,
endovascular distal anastomoses should be closed with a patch or the hood of a more
distal bypass graft to prevent perianastomotic stenoses or occlusions in the postoperative
period. (J Vasc Surg 2000;32:307-14.)
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immediately proximal to the lesion being treated
with either balloon-expandable or self-expanding
stents. Distally, the graft has traditionally been ter-
minated by anchoring it to the external iliac artery
with an additional stent. In our series we have pref-
erentially terminated aortofemoral and iliofemoral
endovascular grafts with hand-sewn anastomoses to
the femoral artery or a more distal patent artery or
bypass graft. We believe that this modification sim-
plifies endovascular grafting by allowing us to use a
standardized length of graft and avoid the need to
deploy a distal stent. In addition, these grafts termi-
nate in the groin, where stents are contraindicated
and where the location and configuration of the
anastomosis can be modified to maximize outflow.
This technique also accommodates the frequent
need for a concomitant crossover or distal bypass
graft procedure. The current report describes our
techniques and the different distal anastomotic con-
figurations that have been used for aortofemoral and
iliofemoral endovascular stented grafts placed to
treat patients with aortoiliac occlusive disease.
METHODS
Informed consent. The use of endovascular
grafts in patients has been evaluated and approved by
the Institutional Review Board of the Montefiore
Medical Center. These procedures were performed
under an Investigational Device Exemption, which
was approved by the Food and Drug Administration.
Informed consent for all procedures was obtained
before the procedure, and the known risks and possi-
ble alternative treatments were discussed with each
patient. The fact that these procedures were new and
unproved was clearly emphasized.
Patient characteristics. Between March 1993
and January 1996, 44 patients with limb-threaten-
ing ischemia and aortoiliac occlusive disease under-
went attempted endovascular bypass grafting. The
use of these bypass grafts was restricted to patients in
whom there were contraindications to standard vas-
cular reconstructive or interventional procedures.
Guidewire passage through occluded arterial seg-
ments could not be accomplished in two patients,
and the procedures were aborted. These patients
were excluded from further analysis. In addition,
four patients received an endovascular graft on each
side to treat bilateral disease. Therefore, the total
number of grafts inserted was 46. The average age of
the remaining 42 patients was 65 years (range, 42-
86 years). Twenty-six patients (62%) were male, 20
(48%) had type 1 diabetes mellitus, 6 (14%) had a
previous lower extremity bypass graft, 33 (79%) had
sustained a previous myocardial infarction or had
undergone coronary artery bypass graft surgery, and
8 (19%) had severe, chronic obstructive pulmonary
disease. The indications for surgery were severe
ischemic rest pain (4 [9%]), ischemic ulceration (11
[24%]), and gangrene (31 [67%]).
Preoperative examination. All patients were
examined preoperatively; the examination included
segmental lower extremity arterial occlusion pres-
sures, pulse volume recordings, standard contrast
angiography, and dynamic spiral computed tomo-
graphic scanning of the abdomen and pelvis. Cardiac
assessment, which included dipyridamole thallium
scanning and coronary angiography, was done on a
selective basis and was restricted to those patients
with symptomatic cardiac disease.
Bypass graft procedures. Twenty-one patients
had an isolated aortofemoral or iliofemoral endolu-
minal bypass graft, and 21 patients had combined
procedures consisting of a standard infrainguinal
bypass graft procedure (femorotibial [2], femoro-
femoral [5], femoropopliteal [14]) in conjunction
with an endoluminal revascularization. Twenty-
seven of the endoluminal bypass grafts originated
within the aorta, whereas the other 19 originated
more distally in the common (18) or proximal exter-
nal iliac arteries (1).
The endoluminal bypass grafts were constructed
from polytetrafluoroethylene (PTFE) grafts that were
25 cm long and had 6-mm diameters (W. L. Gore and
Associates, Flagstaff, Ariz). The PTFE grafts were
attached proximally to a Palmaz balloon-expandable
stent (Johnson and Johnson Interventional Systems,
Warren, NJ) with four interrupted PTFE sutures. The
proximal stent was then manually compressed onto a
balloon angioplasty catheter (Medi-tech, Inc,
Watertown, Mass) and loaded into a 14F coaxial
introducer sheath. The graft was loaded next to the
shaft of a second balloon angioplasty catheter that was
positioned so that its balloon (tip balloon) protruded
from the introducer sheath so as to form a tapered tip
for the device delivery system (Fig 1). After an open
femoral artery exposure and puncture was performed,
a guidewire was then used to traverse the occluded
iliac artery in either a prograde (from the contralater-
al groin) or a retrograde (from the ipsilateral femoral
artery) fashion. The entire length of the occluded ves-
sel was dilated with an angioplasty balloon that had an
8-mm diameter. The endovascular graft was then
introduced in a retrograde, over-the-wire fashion
through a longitudinal arteriotomy. The device was
advanced proximally through the iliac arteries and
positioned so as to completely exclude the diseased
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segment of the artery. The proximal end of the bypass
graft was then anchored to the endoluminal surface of
the arterial wall by inflating the balloon carrying the
Palmaz stent. In selected cases, the proximal portion of
the bypass graft was deployed more distally in the
external iliac artery to preserve flow through a patent
hypogastric artery. The distal end of the graft was
brought out through the common femoral arterioto-
my site and transected (Fig 2). With the use of hand-
sewn techniques, the distal end of each endovascular
graft was individually tailored depending on the paten-
cy of the femoral bifurcation vessels or the presence of
an existing bypass graft. If the deep and superficial
femoral arteries were patent, an endoluminal anasto-
mosis was constructed within the common femoral
artery. Early in our series, the arteriotomy overlying an
endoluminal anastomosis was closed primarily. Later, a
patch angioplasty was performed. Endoluminal anas-
tomoses were also constructed if a distal or crossover
bypass graft originating from the common femoral
artery was required. In these cases, the arteriotomy
was closed with the hood of the bypass graft. Other
anatomic disease configurations were managed with
novel extraluminal anastomoses constructed to maxi-
mize outflow (Figs 3-6). 
Patient follow-up. Segmental lower extremity
arterial occlusion pressures, ankle/brachial indices
(ABIs), arterial pulse volume recordings, duplex ultra-
sound scanning, contrast angiography, and, in select-
ed cases, spiral computed tomographic scanning of
the abdomen and pelvis were performed before dis-
charge from the hospital. The noninvasive studies
(including duplex ultrasound scanning) were repeated
at 1 and 3 months and then every 3 months there-
after. Angiography was performed if there were
diminished pulses on physical examination, if there
was a decrease of more than 0.15 in the ABI, or if sig-
nificant flow abnormalities were detected by duplex
ultrasound scan examination. Mean duration of fol-
low-up was 24 months (range, 2-57 months), and 23
patients (50%) had more than 2 years of follow-up.
Statistical methods. Descriptive statistics for
continuous variables are expressed as the mean ± SD
unless otherwise indicated according to individual
grafts. Patency rates were determined with life table
methods and the guidelines of the Society for
Vascular Surgery and International Society for
Cardiovascular Surgery (North American chapter)
Ad Hoc Committee on Reporting Standards for
Lower Extremity Ischemia.12
RESULTS
The mean postoperative ABI ipsilateral to the
side of the endoluminal bypass grafts was 0.68 ±
0.26 as compared with 0.23 ± 0.22 preoperatively
(P <.01). The ABI increased by more than 0.15 in
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Fig 1. Diagram depicting the components of an endovascular stented graft and delivery sys-
tem, including guidewire (a), guiding balloon (b), proximal stent (c), prosthetic graft (d),
sutures (e), deployment balloon (f), introducer sheath (g), and hemostatic valve (h).
Fig 2. Schematic drawing of an aortofemoral endovascu-
lar graft after deployment of the proximal stent (arrow)
but before construction of the distal anastomosis. The dis-
tal portion of the graft has been brought out through the
common femoral arteriotomy, which was initially created
to allow insertion of the device. 
all but three of the 46 grafts (6.5%). Two patients
had decreased ABIs postoperatively, and one
patient’s ABI was unchanged. The mean peak sys-
tolic flow velocity in the endoluminal bypass grafts
without anastomotic lesions was 118 ± 52 cm/s,
compared with 369 ± 116 cm/s at the distal anasto-
mosis in bypass grafts with stenotic lesions (P < .01).
Distal anastomotic stenoses or occlusions were ini-
tially suspected on physical examination (one
patient) or through duplex ultrasound scan findings
(five patients). Two of the bypass grafts with flow
abnormalities seen on duplex scan examination did
not have stenotic lesions demonstrated on angiogra-
phy and have remained patent without the need for
revision. Early in our experience, 11 patients had
primary closure of a femoral arteriotomy site overly-
ing an intraluminal graft to artery anastomosis.
Three (27%) of these 11 patients were found to have
either a high-grade stenosis (2) or graft occlusion
(1) postoperatively. In 17 patients (21 grafts), patch
angioplasty closure of the arteriotomy overlying the
distal endoluminal anastomosis was performed
either with an elliptic patch of PTFE or with the
proximal end of a more distal bypass graft. None of
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Fig 3. Sutured endovascular anastomosis and overlying
primary arteriotomy closure of an iliofemoral endovascu-
lar graft. Appearance of the anastomosis before comple-
tion (a). This configuration is used when the branches of
the common femoral artery are obstructed.
Fig 4. Right, Distal sutured endovascular graft anastomo-
sis with overlying patch angioplasty. Left, Sagittal section
of endoluminal anastomosis and patch angioplasty. This
anastomotic configuration is used in the presence of a
small or diseased common femoral artery and unobstruct-
ed deep and superficial femoral arteries.
Fig 5. Sutured endoluminal anastomosis with the hood of
a distal bypass graft originating from the arteriotomy over-
lying the endoluminal anastomosis. This configuration is
used for simultaneous revascularization of contralateral
aortoiliac or infrainguinal arterial occlusive disease.
a
these patients experienced an early postoperative
anastomotic stenosis or graft occlusion. In 14 other
patients the endovascular graft was brought out
from the arteriotomy, and an extraluminal anasto-
mosis was constructed to a patent, deep, superficial
femoral or popliteal artery, or to a more distal bypass
graft. Only one of these 15 (7%) endovascular grafts
was found to have a stenosis at its distal anastomosis
(Fig 7). Overall primary and secondary bypass graft
patency at 36 months was 70% and 82%, respective-
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Fig 6. In the presence of significant occlusive disease of the common femoral artery and its
branches or of the contralateral iliac artery, the distal portion of the endovascular grafts are
brought out from the arterial lumen, and anastomoses are fashioned as follows: A, end-to-side
configuration of the graft to the deep femoral artery; B, end-to-end (or end-to-side) anastomosis
to a concomitant deep femoral-popliteal bypass graft; C, endovascular graft extended directly to
the popliteal artery because of diffuse disease of the superficial femoral and deep femoral arteries;
D, femoral-femoral bypass graft originating from the distal externalized portion of the endolu-
minal bypass graft. 
A B
C D
ly. The primary patencies for the aortofemoral and
iliofemoral endovascular grafts were 69% and 72%,
respectively, at 36 months (Table I). Secondary
patency was 81% for the aortofemoral grafts and 84%
for the iliofemoral grafts over this same interval
(Table II).* There was no significant difference in
the primary and secondary patency rates of the
aortofemoral as compared with the iliofemoral
endovascular grafts as assessed with the log-rank
tests (P = .75 and P = .61, respectively). With the use
of the log-rank tests of survival for the two graft
types and a constant hazard ratio, the observed dif-
ferences were calculated to have 40% power.
DISCUSSION
Endovascular stented grafts are a new but
unproven alternative to conventional arterial recon-
structive procedures. Because the need for open sur-
gical repair is reduced or eliminated, use of endovas-
cular graft techniques appear to be an attractive
option for the treatment of a wide range of peripher-
al vascular problems, especially in patients who have
contraindications to standard open operative repair.
To date, endovascular grafts have been used to treat
long-segment aortoiliac occlusive lesions, inaccessible
arteriovenous fistulas and false aneurysms, and isolat-
ed infrarenal aortic and iliac artery aneurysms.
Despite favorable early reports, their precise role in
the management of these lesions has yet to be fully
defined.
Although the concept of endovascular grafting
is simple, its application is technically demanding.
Subtle discrepancies between the length or diameter
of a graft and the native artery may result in an inef-
fective bypass graft caused by a graft that is too short
or too small. Alternatively, buckling can occur in a
graft that is too long or too wide for the vessel being
treated, and the result could be flow disturbances or
thrombosis. In addition, longitudinal positioning
errors and axial twists of the graft or the presence of
obstructing lesions proximal or distal to an endovas-
cular graft can result in the graft’s failure. Despite the
use of several anastomotic variations, a standard
length of graft can be used to construct our endovas-
cular devices. The axial orientation of the graft can be
maintained with manual control of the distal portion
of the graft, and the exact graft length needed for
each patient can then be determined once the loca-
tion of the distal anastomosis is chosen. The need for
precise graft and arterial measurements before and
during placement is thereby minimized. 
When endovascular grafts are terminated in the
external iliac artery, the artery distal to the graft
may be diseased and develop obstructing lesions if
not appropriately treated. This problem applies to
the use of stents as well as endovascular grafts.
Laborde et al13 observed a higher failure rate in
patients who had stents placed for occlusive disease
involving the external iliac arteries than in those
who had stents placed for occlusive lesions of the
common iliac arteries. Others have reported in-
creased early failure rates using endovascular stent-
ed grafts terminating in the external iliac arteries.14
These failures may have occurred because the occlu-
sive lesions extended beyond the most distal por-
tion of the stented grafts. The importance of
extending standard arterial bypass grafts to the
femoral arteries when aortoiliac occlusive disease is
treated has been clearly recognized since 1968.15
This basic principle is also probably applicable to
endovascular grafts placed for the treatment of 
aortoiliac occlusive disease as well. 
Stent termination of endovascular grafts in the
region of the femoral arteries has previously been
avoided, primarily because of the fear that the stents
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Fig 7. Angiogram demonstrating a high-grade stenosis
(arrow) of the common femoral artery at the site of a dis-
tal endovascular graft anastomosis performed without an
overlying patch angioplasty.
*The statistical analyses reported in the manuscript assume inde-
pendence of each implanted graft. If the data are analyzed with
respect to the first graft implanted for each patient with bilateral
grafts (true independence), the primary and secondary patencies
are 65% and 79%, respectively, for the aortofemoral grafts and
79% and 92%, respectively, for the iliofemoral grafts.
may become compressed or interfere with subse-
quent conventional interventions. To minimize
these problems and to tailor the distal anastomoses
to the local vascular pathology, we have developed
new techniques. Our endovascular grafts are
anchored proximally in a conventional fashion with
a Palmaz stent. The distal portion of the graft is
anastomosed within the common femoral artery
(with the femoral arteriotomy site through which
the graft delivery system is inserted). With this
approach, the entire iliac segment is therefore
bypassed, and the need for a distal stent is avoided.
Alternatively, grafts can be brought out of the lumen
of the common femoral artery and anastomosed to a
more distal patent arterial segment or bypass graft.
The different anastomotic configurations used in
our series are therefore not suitable for construction
in all patients. Rather, the choice of the outflow vas-
culature must be varied to include any of the infrain-
guinal vessels or a more distal graft depending on an
individual patient’s pattern of occlusive disease.
However, on the basis of our anecdotal experience
with anastomotic stenoses and graft failure after pri-
mary arteriotomy closure, we now routinely patch
the arteriotomy closed. 
The combination of endovascular and open surgi-
cal techniques have therefore simplified the perfor-
mance of endoluminal bypass grafts and enabled
endovascular grafts to be terminated in an infrain-
guinal location. In addition, they have increased the
options for bypassing diseased outflow vessels and have
extended our ability to treat diffuse aortoiliac and
femoral artery occlusive lesions in patients with limb-
threatening ischemia and serious comorbidities that
may preclude more standard vascular treatments.
We very much appreciate the work of Cathy Freeman,
PhD, who performed the statistical analysis of the data in
this study.
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